A new conceptual article published in eGastroenterology proposes that metabolic dysfunction-associated steatotic liver disease (MASLD), metabolic dysfunction and alcohol-associated liver disease (MetALD), and alcohol-associated liver disease (ALD) should be viewed as a dynamic continuum rather than fixed diagnostic entities. The authors highlight how fluctuations in alcohol intake and metabolic dysfunction drive transitions across disease categories over time. The work also emphasizes objective